CytomX to Present at the Cantor Fitzgerald Healthcare Conference

World News: . []

SOUTH SAN FRANCISCO, Calif., Sept. 13, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will present at the Cantor Fitzgerald Healthcare Conference.  Sean McCarthy, D.Phil., president and chief executive officer, will deliver a corporate overview on Wednesday, September 27, 2017, at 1:05 p.m. ET.

A live audio webcast of the presentation will be available through the  of CytomX's website. An archived replay will be available for 90 days following the event.

More news and information about CytomX Therapeutics Inc.

Published By:

Globe Newswire: 21:05 GMT Wednesday 13th September 2017

Published: .

Search for other references to "cytomx" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2017. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers